Starting a business has always been a risky financial undertaking. With the huge rise in health insurance costs over the last decade, I’m increasingly worried we have created an enormous new obstacle that discourages and slows down the growth trajectory of new businesses. This post is not about rehashing the debates over the federal healthcare … Continue reading “Want to Create More Startups? Do More to Corral Health Insurance Costs”
Author: David Miller
David D. Miller co-founded Biotech Stock Research LLC in 1999 to provide an independent research source for investors in publicly-traded biotech companies. With a background as a company CEO, technical analyst, and market commentator, he provides a uniquely unabashed analysis of the sector and companies in BSR's coverage universe. David has been quoted in nearly every major US newspaper, appeared on financial television multiple times, and authored a chapter entitled ?The Keys to Biotech Investing? in the popular Wiley Financial Press book Master Traders (2006, edited by Fari Hamzei).
DC Matters, But Biotech Can’t Neglect City Hall
Biotechnology companies who’ve taken time to focus on politics over the last few years have focused most of their attention on national-level issues. That’s understandable given the renewal of the Prescription Drug User Fee Act that controls FDA deadlines for reviewing new drug applications, legislation that would make it possible for makers of cheaper “biosimilar” … Continue reading “DC Matters, But Biotech Can’t Neglect City Hall”